It seems chronic stress has a fringe benefit: It protects women from breast cancer. A recent prospective cohort study of almost 7,000 women participating in the Copenhagen City heart study finds that women with self-perceived high levels of stress have a 40% lower risk of first-time primary breast cancer than less stressed counterparts.
It seems chronic stress has a fringe benefit: It protects women from breast cancer. A recent prospective cohort study of almost 7,000 women participating in the Copenhagen City heart study finds that women with self-perceived high levels of stress have a 40% lower risk of first-time primary breast cancer than less stressed counterparts.
During 12 years of follow-up, 251 women in the study were diagnosed with breast cancer. Compared with women with low stress levels, those who were highly stressed had a hazard ratio of 0.60 (95% CI; 0.37–0.97) for breast cancer. In addition, each increase in stress level on a 6-point stress scale was associated with an 8% lower risk of primary breast cancer (hazard ratio [HR] 0.92; 0.85–0.99).
The researchers surmise the connection is based on the ability of chronic stress to impair estrogen synthesis, and high endogenous concentrations of estrogen are a known risk factor for breast cancer. The authors of the study caution, however, that the cumulative health effects of ongoing, intense stress may outweigh the protection offered against breast cancer.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More